X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs ALKEM LABORATORIES - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN LTD ALKEM LABORATORIES LUPIN LTD/
ALKEM LABORATORIES
 
P/E (TTM) x 16.6 - - View Chart
P/BV x 3.9 6.1 63.2% View Chart
Dividend Yield % 0.8 0.7 112.5%  

Financials

 LUPIN LTD   ALKEM LABORATORIES
EQUITY SHARE DATA
    LUPIN LTD
Mar-16
ALKEM LABORATORIES
Mar-16
LUPIN LTD/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs2,1271,589 133.9%   
Low Rs1,2941,232 105.0%   
Sales per share (Unadj.) Rs304.1417.5 72.8%  
Earnings per share (Unadj.) Rs50.456.3 89.5%  
Cash flow per share (Unadj.) Rs60.764.7 93.8%  
Dividends per share (Unadj.) Rs7.5012.70 59.1%  
Dividend yield (eoy) %0.40.9 48.7%  
Book value per share (Unadj.) Rs243.8292.9 83.2%  
Shares outstanding (eoy) m450.58119.57 376.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.63.4 166.5%   
Avg P/E ratio x33.925.1 135.5%  
P/CF ratio (eoy) x28.221.8 129.3%  
Price / Book Value ratio x7.04.8 145.7%  
Dividend payout %14.922.6 66.0%   
Avg Mkt Cap Rs m770,740168,653 457.0%   
No. of employees `00016.4NA-   
Total wages/salary Rs m21,0779,171 229.8%   
Avg. sales/employee Rs Th8,379.6NM-  
Avg. wages/employee Rs Th1,289.0NM-  
Avg. net profit/employee Rs Th1,388.7NM-  
INCOME DATA
Net Sales Rs m137,01649,915 274.5%  
Other income Rs m1,8771,645 114.1%   
Total revenues Rs m138,89351,561 269.4%   
Gross profit Rs m37,5358,482 442.5%  
Depreciation Rs m4,6351,006 460.8%   
Interest Rs m446671 66.5%   
Profit before tax Rs m34,3308,451 406.2%   
Minority Interest Rs m-88-114 77.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m11,5361,606 718.3%   
Profit after tax Rs m22,7076,731 337.3%  
Gross profit margin %27.417.0 161.2%  
Effective tax rate %33.619.0 176.8%   
Net profit margin %16.613.5 122.9%  
BALANCE SHEET DATA
Current assets Rs m97,79027,062 361.4%   
Current liabilities Rs m53,87215,324 351.6%   
Net working cap to sales %32.123.5 136.3%  
Current ratio x1.81.8 102.8%  
Inventory Days Days8567 127.3%  
Debtors Days Days12141 293.6%  
Net fixed assets Rs m86,37912,610 685.0%   
Share capital Rs m901239 376.9%   
"Free" reserves Rs m105,73534,490 306.6%   
Net worth Rs m109,84435,027 313.6%   
Long term debt Rs m53,7391,212 4,435.4%   
Total assets Rs m224,37854,387 412.6%  
Interest coverage x77.913.6 573.0%   
Debt to equity ratio x0.50 1,414.3%  
Sales to assets ratio x0.60.9 66.5%   
Return on assets %10.313.6 75.8%  
Return on equity %20.719.2 107.6%  
Return on capital %21.224.9 85.3%  
Exports to sales %49.112.9 379.1%   
Imports to sales %7.43.1 241.2%   
Exports (fob) Rs m67,2446,461 1,040.8%   
Imports (cif) Rs m10,1991,540 662.2%   
Fx inflow Rs m71,4056,563 1,087.9%   
Fx outflow Rs m17,8073,012 591.3%   
Net fx Rs m53,5983,552 1,509.1%   
CASH FLOW
From Operations Rs m-3,6907,259 -50.8%  
From Investments Rs m-69,4341,864 -3,724.6%  
From Financial Activity Rs m58,126-9,273 -626.9%  
Net Cashflow Rs m-14,998-150 9,998.7%  

Share Holding

Indian Promoters % 46.6 66.9 69.7%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 33.1 34.1%  
FIIs % 31.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 0.0 -  
Shareholders   98,259 68,381 143.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN LTD With:   J.B.CHEMICALS  SUVEN LIFE  CIPLA  CADILA HEALTHCARE  VENUS REMEDIES  

Compare LUPIN LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Vishal Sikka's Infosys Exit, White House Shake up & Cues to Watch Out Today(Pre-Open)

Indian share markets ended lower on Friday but gained during the overall week. At the closing bell on Friday, BSE Sensex closed lower by 271 points and the NSE Nifty finished down 67 points.

Related Views on News

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Aug 18, 2017 (Close)

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LUPIN LTD - SUVEN LIFE COMPARISON

COMPARE LUPIN LTD WITH

MARKET STATS